Sponsor pipeline

Lumos Pharma clinical trial pipeline

Get alerts when Lumos Pharma's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1
1
Phase 2
3
Phase 3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT06948214 Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency Growth Hormone Deficiency (GHD) Recruiting 2026-10-09
NCT07129759 Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone… Growth Hormone Deficiency (GHD) Not Yet Recruiting 2026-07-08
Phase 2
NCT07754045 Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus… Obesity & Overweight Not Yet Recruiting 2026-08-10
NCT05796440 A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency… Growth Hormone Deficiency Enrolling by Invitation 2024-02-15
NCT04806854 PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency… Growth Hormone Deficiency Active, Not Recruiting 2023-10-04
Phase 1
NCT07732413 Trial of NLG802 Indoximod Prodrug Plus Temozolomide for Patients With Progressive… Progressive Pediatric Brain Cancer Not Yet Recruiting 2026-07-28

Disease areas by active trials

Get alerts when Lumos Pharma's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free